Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy

PURPOSE: The aim of this study was to investigate the potential of the synergetic triple therapeutic combination encompassing bismuth oxide nanoparticles (BiONPs), cisplatin (Cis), and high dose rate (HDR) brachytherapy with Ir-192 source in breast cancer and normal fibroblast cell line. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisin, Noor Nabilah Talik, Abdul Razak, Khairunisak, Zainal Abidin, Safri, Che Mat, Nor Fazila, Abdullah, Reduan, Ab Rashid, Raizulnasuha, Khairil Anuar, Muhammad Afiq, Mohd Zainudin, Nur Hamizah, Tagiling, Nashrulhaq, Mat Nawi, Norazlina, Rahman, Wan Nordiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927229/
https://www.ncbi.nlm.nih.gov/pubmed/31908451
http://dx.doi.org/10.2147/IJN.S228919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927229/
https://www.ncbi.nlm.nih.gov/pubmed/31908451
http://dx.doi.org/10.2147/IJN.S228919

Ejemplares similares